Harmony Biosciences Holdings (HRMY) Other Non-Current Assets (2019 - 2026)

Harmony Biosciences Holdings has disclosed Other Non-Current Assets across 8 years of filings, most recently posting $26.4 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $26.4 million, up 9690.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.4 million (up 9690.0% YoY), and the FY2025 annual result was $18.4 million, up 147.85% from the prior year.
• Other Non-Current Assets came in at $26.4 million for Q1 2026 at Harmony Biosciences Holdings, up from $18.4 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $26.4 million in Q1 2026 to a low of $250000.0 in Q2 2023.
• The 5-year median for Other Non-Current Assets is $750000.0 (2022), against an average of $4.5 million.
• Across the five-year window, Other Non-Current Assets plunged 78.66% in 2022 and surged 9690.0% in 2026, its largest moves.
• Harmony Biosciences Holdings' Other Non-Current Assets stood at $750000.0 in 2022, then soared by 739.73% to $6.3 million in 2023, then grew by 17.7% to $7.4 million in 2024, then surged by 147.85% to $18.4 million in 2025, then soared by 43.87% to $26.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $26.4 million (Q1 2026), $18.4 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.